BE862630A - NEW PHTHALIMIDO-SULFAMIDES AND PROCESS FOR THEIR PREPARATION - Google Patents

NEW PHTHALIMIDO-SULFAMIDES AND PROCESS FOR THEIR PREPARATION

Info

Publication number
BE862630A
BE862630A BE184096A BE184096A BE862630A BE 862630 A BE862630 A BE 862630A BE 184096 A BE184096 A BE 184096A BE 184096 A BE184096 A BE 184096A BE 862630 A BE862630 A BE 862630A
Authority
BE
Belgium
Prior art keywords
emi
preparation
phthalimido
new
mono
Prior art date
Application number
BE184096A
Other languages
French (fr)
Inventor
Angel Lazaro Porta
Pedro Sola Mir
Original Assignee
Andreu Sa Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andreu Sa Dr filed Critical Andreu Sa Dr
Publication of BE862630A publication Critical patent/BE862630A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • C07D261/16Benzene-sulfonamido isoxazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

       

  Nouveaux phtalimido-sulfamides et

  
procédé pour leur préparation La présente invention concerne de nouveaux dérivés de sulfamides et un procédé pour leur préparation.

  
Les nouveaux dérivés de l'invention répondent

  
à la formule de structure générale

  

 <EMI ID=1.1> 


  
 <EMI ID=2.1> 

  
molécule de sulfamide de l'une des formules

  

 <EMI ID=3.1> 


  

 <EMI ID=4.1> 


  
Ces nouveaux dérivés peuvent être préparés en faisant réagir l'anhydride phtalique en milieu basique,

  
 <EMI ID=5.1> 

  
Dans le premier cas, on obtient le mono-phtalimide de la sulfaquinoxaline de la formule

  

 <EMI ID=6.1> 


  
dans le deuxième cas, le mono-phtalimide du sulfamétoxazole de la formule

  

 <EMI ID=7.1> 


  
La préparation des nouveaux dérivés de l'invention est illustrée par les exemples non limitatifs de modes de réalisation ci-après.

Exemple 1

  
Préparation du monophtalimide de sulfaquinoxaline Dans un erlenmeyer avec agitateur mécanique,

  
on introduit 75 ml d'eau et 13 g (43,3 idoles) de sulfaquinoxaline, on y ajoute une solution aqueuse à 48% d'hydroxyde de sodium jusqu'au pH de 10,7, puis par petites portions

  
un total de 6,75 g (45,6 mmoles) d'anhydride phtalique pulvérulent, le pH étant maintenu au voisinage de 9,4.

  
Après addition complète de l'anhydride phtalique,

  
on agite le mélange réactionnel pendant 2 heures en ajoutant

  
 <EMI ID=8.1> 

  
de sodium suffisante pour maintenir le pH entre 8 et 9,4.

  
Après filtration de la solution réactionnelle

  
 <EMI ID=9.1>  avec de l'acide chlorhydrique concentré au pH de 5, puis avec de l'acide acétique jusqu'au pH de 3.

  
 <EMI ID=10.1> 

  
et lavé à l'eau jusqu'à neutralité. Par séchage à 4[deg.]C sous vide, on obtient 17,3 g d'un produit solide, qui est

  
 <EMI ID=11.1> 

  
est chauffée à reflux pendant 2 heures, puis filtrée et 

  
 <EMI ID=12.1> 

  
Le précipité, qui se forme au refroidissement,  est séparé par filtration, lavé à l'acétate d'éthyle et  séché sous vide. On obtient 10 g, soit 51% du rendement  théorique, du composé indiqué en tête, d'un point de fusion 

  
de 191-192[deg.]C (avec décomposition). 

  
Analyse :

  

 <EMI ID=13.1> 

Exemple 2

  
Préparation du mono-phtalimide du sulfaméthoxazole

  
 <EMI ID=14.1> 

  
solution aqueuse à 48% d'hydroxyde de sodium, puis ajoute par petites portions et en maintenant le pH à 9,4 un total de 7,95 g (53,7 mmoles) d'anhydride phtalique pulvérulent.

  
Ce mélange réactionnel est agité jusqu'à dissolution complète avec addition périodique de solution, à 48% d'hydroxyde de sodium pour maintenir le pH entre 8 et 10. 

  
 <EMI ID=15.1> 

  
Apres une agitation de 60 mn, la solution est filtrée pour éliminer le résidu insoluble et le filtrat est acidifié au pH de 3.

  
Le précipité formé est séparé par filtration et lavé à l'eau, puis séché dans une étuve à vide à 40[deg.]C.

  
On obtient 14 g, soit 80,5% du rendement théorique, du composé indiqué en tête, d'un point de fusion de 196-198[deg.]C. Analyse :

  
calculé : C 53,86 ; H 3,76 ; N 10,47 ; S 7,99 % ;

  
trouvé : C 53,67 ; H 3,60 ; N 10,74 ; S 8, 08 %.

REVENDICATIONS

  
1. Mono-phtalimido-sulfamide de la formule de structure générale :

  

 <EMI ID=16.1> 


  
dans laquelle le symbole R représente le reste d'une molécule de sulfamide de l'une des formules

  

 <EMI ID=17.1> 


  

 <EMI ID=18.1> 


  
2. Procédé de préparation d'un mono-phtalimido-



  New phthalimido-sulfonamides and

  
Process for their preparation The present invention relates to novel sulfonamide derivatives and to a process for their preparation.

  
The new derivatives of the invention meet

  
to the general structure formula

  

 <EMI ID = 1.1>


  
 <EMI ID = 2.1>

  
sulfonamide molecule of one of the formulas

  

 <EMI ID = 3.1>


  

 <EMI ID = 4.1>


  
These new derivatives can be prepared by reacting phthalic anhydride in a basic medium,

  
 <EMI ID = 5.1>

  
In the first case, we obtain the mono-phthalimide of sulfaquinoxaline of the formula

  

 <EMI ID = 6.1>


  
in the second case, sulfametoxazole mono-phthalimide of the formula

  

 <EMI ID = 7.1>


  
The preparation of the new derivatives of the invention is illustrated by the non-limiting examples of embodiments below.

Example 1

  
Preparation of sulfaquinoxaline monophthalimide In an Erlenmeyer flask with mechanical stirrer,

  
75 ml of water and 13 g (43.3 idols) of sulfaquinoxaline are introduced, a 48% aqueous solution of sodium hydroxide is added to it up to the pH of 10.7, then in small portions

  
a total of 6.75 g (45.6 mmol) of powdery phthalic anhydride, the pH being maintained in the vicinity of 9.4.

  
After complete addition of phthalic anhydride,

  
the reaction mixture is stirred for 2 hours adding

  
 <EMI ID = 8.1>

  
sodium sufficient to maintain the pH between 8 and 9.4.

  
After filtration of the reaction solution

  
 <EMI ID = 9.1> with concentrated hydrochloric acid to pH 5, then with acetic acid to pH 3.

  
 <EMI ID = 10.1>

  
and washed with water until neutral. By drying at 4 [deg.] C under vacuum, 17.3 g of a solid product are obtained, which is

  
 <EMI ID = 11.1>

  
is heated at reflux for 2 hours, then filtered and

  
 <EMI ID = 12.1>

  
The precipitate, which forms on cooling, is separated by filtration, washed with ethyl acetate and dried in vacuo. 10 g, or 51% of the theoretical yield, of the compound indicated at the head, with a melting point are obtained

  
of 191-192 [deg.] C (with decomposition).

  
Analysis:

  

 <EMI ID = 13.1>

Example 2

  
Preparation of sulfamethoxazole mono-phthalimide

  
 <EMI ID = 14.1>

  
48% aqueous sodium hydroxide solution, then added in small portions and maintaining the pH at 9.4 a total of 7.95 g (53.7 mmol) of powdered phthalic anhydride.

  
This reaction mixture is stirred until complete dissolution with periodic addition of a 48% sodium hydroxide solution to maintain the pH between 8 and 10.

  
 <EMI ID = 15.1>

  
After stirring for 60 minutes, the solution is filtered to remove the insoluble residue and the filtrate is acidified to pH 3.

  
The precipitate formed is separated by filtration and washed with water, then dried in a vacuum oven at 40.degree.

  
14 g, ie 80.5% of the theoretical yield, of the compound indicated at the head, with a melting point of 196-198 [deg.] C are obtained. Analysis:

  
calculated: C 53.86; H 3.76; N 10.47; S 7.99%;

  
found: C 53.67; H 3.60; N 10.74; S, 8.08%.

CLAIMS

  
1. Mono-phthalimido-sulfonamide of the general structural formula:

  

 <EMI ID = 16.1>


  
in which the symbol R represents the remainder of a sulfonamide molecule of one of the formulas

  

 <EMI ID = 17.1>


  

 <EMI ID = 18.1>


  
2. Process for preparing a mono-phthalimido-


    

Claims (1)

sulfamide suivait la revendication 1, caractérisé en ce que l'on fait réagir l'anhydride phtalique en milieu basique, à un pH compris entre 8 et 10, soit avec la sulfaquino- <EMI ID=19.1> sulfonylurea followed claim 1, characterized in that phthalic anhydride is reacted in a basic medium, at a pH between 8 and 10, or with sulfaquino- <EMI ID = 19.1> 3. Procédé suivant la revendication 2, caractérisé en ce que le composé recherché est précipite à l'état cristallisé par acidification de la solution réactionnelle jusqu'au pH de 3. 3. Method according to claim 2, characterized in that the desired compound is precipitated in the crystalline state by acidification of the reaction solution to the pH of 3. 4. Le mono-phtalimide de la sulfaquinoxaline. 4. Sulfaquinoxaline mono-phthalimide. 5. Le mono-phtalimide du sulfaméthoxazole. 5. Sulfamethoxazole mono-phthalimide.
BE184096A 1977-09-29 1978-01-04 NEW PHTHALIMIDO-SULFAMIDES AND PROCESS FOR THEIR PREPARATION BE862630A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES462774A ES462774A1 (en) 1977-09-29 1977-09-29 Procedure for the obtaining of new ftalil derivatives of sulfamides. (Machine-translation by Google Translate, not legally binding)

Publications (1)

Publication Number Publication Date
BE862630A true BE862630A (en) 1978-05-02

Family

ID=8474602

Family Applications (1)

Application Number Title Priority Date Filing Date
BE184096A BE862630A (en) 1977-09-29 1978-01-04 NEW PHTHALIMIDO-SULFAMIDES AND PROCESS FOR THEIR PREPARATION

Country Status (2)

Country Link
BE (1) BE862630A (en)
ES (1) ES462774A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049685A3 (en) * 1999-12-31 2002-02-14 Texas Biotechnology Corp Sulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
WO2001049685A3 (en) * 1999-12-31 2002-02-14 Texas Biotechnology Corp Sulfonamides and derivatives thereof that modulate the activity of endothelin
US6686382B2 (en) 1999-12-31 2004-02-03 Encysive Pharmaceuticals Inc. Sulfonamides and derivatives thereof that modulate the activity of endothelin

Also Published As

Publication number Publication date
ES462774A1 (en) 1978-05-16

Similar Documents

Publication Publication Date Title
EP0719254B1 (en) Method for the preparation of high purity substituted benz e]indoles and the alkaline salts thereof
US5889183A (en) β-Aminoethanesulphonylazide their use for the preparation of 2-aminoethane-sulphonamide (taurylamide), taurolidine or taurultam and their acid addition salts
EP0325537B1 (en) Process for the synthesis of 3&#39;-azido-3&#39;-deoxythymidine and the like
BE862630A (en) NEW PHTHALIMIDO-SULFAMIDES AND PROCESS FOR THEIR PREPARATION
BE779775A (en) DERIVATIVES OF UREA, METHOD FOR PREPARING THEM AND THEIR APPLICATIONS
US4692545A (en) Method for preparation of mercaptobenzoates
JP2518014B2 (en) Method for purifying α-substituted acetic acid
US4236017A (en) Process for synthesizing 2-substituted semicarbazones and carbalkoxy hydrazones
JP3089373B2 (en) Method for producing 2-mercapto-phenothiazine
EP0363263B1 (en) Process for the preparation of propionic-acid derivatives
US4751314A (en) Preparation of tetrachloro-3-iminoisoindolin-1-one
BE858864A (en) NEW ESTERS OF PHENYL- AND PYRIDINE-3-CARBOXYLIC ACIDS AND PROCESS FOR THEIR PREPARATION
FR2574792A1 (en) PROCESS FOR THE PREPARATION OF PYRROLIDINE DERIVATIVES
EP0627403B1 (en) Method for the production of hydroxyphenylacetic acids
US4546203A (en) Facile synthesis of β-hydroxy-β-methylglutaric acid
JPH07330729A (en) Production of 1,3-diiminoisoindoline derivative
FR2513638A1 (en) PROCESS FOR THE PREPARATION OF VINCAMINE ACID ESTERS
JPS60169493A (en) Preparation of 5-deoxy-l-arabinose
JPS59186986A (en) Preparation of 1&#39;,2&#39;-diacyl-l-biopterin
FR2536393A1 (en) New aminoketones, process for preparing them and their therapeutic use
BE890069A (en) PROCESS FOR THE PREPARATION OF ALIPHATIC HYDROXY-PHENYL ACID DERIVATIVES AND CATALYST USEFUL THEREFOR
FR2725201A1 (en) PROCESS FOR THE PREPARATION OF NITROBENZENE DERIVATIVES
CA2086923A1 (en) Vinylsulphonyl pristinamycin and preparation thereof
FR2495143A1 (en) PROCESS FOR THE PREPARATION OF 1- (3,5-DIMETHOXY-4-HYDROXY PHENYL) -2- (N-METHYLAMINO) ETHANOL HYDROCHLORIDE
JPS63280084A (en) Manufacture of 1-alkyl-3-carboxy-4-cinnolones